Surveillance Trial to Evaluate a Shortened Infusion Time of Intravenous Ibuprofen
- Registration Number
- NCT01334944
- Lead Sponsor
- Cumberland Pharmaceuticals
- Brief Summary
The primary objective of this study is to determine the safety of a single dose of intravenous ibuprofen administered over 5-10 minutes for the treatment of fever or pain in the hospital setting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
- Pain: Patients with baseline Visual Analog Scale assessment >3, -and/or- Fever: Patients with temperature >101°F.
- Patients with inadequate IV access
- Patients <18 years of age
- History or allergy or hypersensitivity to any component of intravenous ibuprofen, aspirin (or aspirin related products) or non-steroidal anti-inflammatory drug (NSAIDs)
- Active hemorrhage or clinically significant bleeding
- Pregnant or nursing
- Patients in the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery
- Inability to understand the requirements of the study, be willing to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]), and agree to abide by the study restrictions
- Refusal to provide written authorization for use and disclosure of protected health information
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Intravenous ibuprofen Intravenous ibuprofen Intravenous ibuprofen (400 mg or 800 mg intravenous ibuprofen administered intravenously over 5-10 minutes) will be administered as a single dose during the 5-10 minute Treatment Period.
- Primary Outcome Measures
Name Time Method To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain in the Hospital Setting. 1 hour The change from baseline to one hour post administration of intravenous ibuprofen in vital sign assessments (Diastolic Blood Pressure).
To Determine the Safety of a Single Dose of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain in the Hospital Setting 1 hour The change from baseline to one hour post administration of intravenous ibuprofen in vitals sign assessments (Temperature)
- Secondary Outcome Measures
Name Time Method To Determine the Efficacy of a Single Dose of 400 mg Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever 4 hours The change in temperature from baseline over the 4 hours following intravenous ibuprofen administration
To Determine the Efficacy of a Single Dose of 800 mg Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Pain (Mild to Moderate or Moderate to Severe). 4 hours The change in patient self-assessment of pain utilizing the visual analog scale (VAS) from baseline over the 4 hours following intravenous ibuprofen administration. The VAS is a continuous scale compromised of a horizontal line, one hundred millimeters in length, anchored by 2 verbal descriptors (No Pain, Worst Possible Pain). The VAS is self-completed by the respondent. The respondent is asked to place a line perpendicular to the VAS line at the point that represents their pain intensity. Using a ruler, the score is determined by measuring the distance, in mm, on the 100 mm line between the "No Pain" anchor and the subject's mark. The score would be between o and 100.
To Determine the Safety of a Multiple Doses of Intravenous Ibuprofen Administered Over 5-10 Minutes for the Treatment of Fever or Pain 24 hours The incidence of treatment-emergent adverse events occurring through extended dosing.
Trial Locations
- Locations (13)
Duke University Medical Center
🇺🇸Durham, North Carolina, United States
UCSD
🇺🇸San Diego, California, United States
The Moses H. Cone Memorial Hospital
🇺🇸Greensboro, North Carolina, United States
Grady
🇺🇸Atlanta, Georgia, United States
University of Miami - Miller School of Medicine
🇺🇸Miami, Florida, United States
Columbia
🇺🇸New York, New York, United States
Lankenau
🇺🇸Wynnewood, Pennsylvania, United States
Beth Israel Deaconnes MC
🇺🇸Boston, Massachusetts, United States
The Ohio State University Medical Center
🇺🇸Columbus, Ohio, United States
Fairview
🇺🇸Cleveland, Ohio, United States
The University of North Carolina Hospitals
🇺🇸Chapel Hill, North Carolina, United States
Wake Forest University Baptist Medical Center
🇺🇸Winston-Salem, North Carolina, United States
Danbury
🇺🇸Danbury, Connecticut, United States